• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半透明带试验:其在辅助生殖中识别男性因素不孕症方面的作用。

The hemizona assay: its role in identifying male factor infertility in assisted reproduction.

作者信息

Franken D R, Acosta A A, Kruger T F, Lombard C J, Oehninger S, Hodgen G D

机构信息

Department of Obstetrics and Gynaecology, University of Stellenbosch, Tygerberg Hospital, South Africa.

出版信息

Fertil Steril. 1993 May;59(5):1075-80. doi: 10.1016/s0015-0282(16)55931-7.

DOI:10.1016/s0015-0282(16)55931-7
PMID:8486177
Abstract

OBJECTIVES

To identify male factor infertility among a group of patients in an assisted reproductive program (phase 1) and to evaluate the hemizona assay (HZA) in the diagnosis and prognosis of such a program (phase 2).

DESIGN

The IVF performance of normal gametes in the Tygerberg program were critically evaluated. Female patients were classified as pure tubal factor infertility, having a normal FSH:LH ratio on day 3 of the menstrual cycle. All participating women produced three or more preovulatory oocytes at retrieval and were inseminated with sperm considered normal by all present diagnostic criteria. The total and normal fertilization rate thresholds were defined in that group. Using those thresholds, couples tested for sperm binding in the HZA (n = 48) were used and divided into two groups according to their fertilization rates, namely group 1, low fertilization (< 55%) and group 2, normal fertilization (> 55%).

SETTING

University-based tertiary care center.

PATIENTS

Ninety-nine couples (589 oocytes) with pure tubal factor infertility and normal male factor were used in phase 1. Forty-eight couples with normal and abnormal male factors that had both HZA performed and IVF treatment were included in phase 2.

RESULTS

Investigation of the performance of normal gametes in 99 couples (589 oocytes) revealed the total fertilization rate (total number of oocytes fertilized/total number of oocytes inseminated) was (mean +/- SD) 88.6% +/- 16.8% and the normal fertilization rate (total number of oocytes with normal fertilization/total number of oocytes inseminated) was 81.3% +/- 22%. The minimum total fertilization rate that can be considered normal in the Tygerberg program using mean--2 SD is therefore 55% and for normal fertilization rate is 37%. The group with low fertilization rate (< 55%) showed a mean hemizona index (HZI) significantly lower; nevertheless, the distribution overlapping indicates a low discriminating power of the HZA. A sensitivity of 75% and a specificity of 75% were found; the positive and negative predictive values were 81% and 68%, respectively.

CONCLUSIONS

The results indicated the HZA and HZI contribute important information and can serve in conjunction with other semen characteristics as useful tools during the diagnosis of the male factor in assisted reproduction.

摘要

目的

在一个辅助生殖项目中识别一组患者中的男性因素不育症(第一阶段),并评估半透明带试验(HZA)在该项目诊断和预后中的作用(第二阶段)。

设计

对泰格堡项目中正常配子的体外受精表现进行严格评估。女性患者被归类为单纯输卵管因素不育症,月经周期第3天促卵泡生成素:促黄体生成素比值正常。所有参与的女性在取卵时产生三个或更多排卵前卵母细胞,并用所有现有诊断标准认定为正常的精子进行授精。在该组中定义了总受精率和正常受精率阈值。使用这些阈值,对进行HZA精子结合测试的夫妇(n = 48)进行研究,并根据其受精率分为两组,即第1组,低受精率(< 55%)和第2组,正常受精率(> 55%)。

地点

大学附属三级医疗中心。

患者

第一阶段使用了99对(589个卵母细胞)患有单纯输卵管因素不育症且男性因素正常的夫妇。第二阶段纳入了48对进行了HZA和体外受精治疗、男性因素正常和异常的夫妇。

结果

对99对夫妇(589个卵母细胞)中正常配子表现的研究表明,总受精率(受精的卵母细胞总数/授精的卵母细胞总数)为(平均值±标准差)88.6%±16.8%,正常受精率(正常受精的卵母细胞总数/授精的卵母细胞总数)为81.3%±22%。因此,在泰格堡项目中使用平均值减2个标准差可认为正常的最低总受精率为55%,正常受精率为37%。低受精率组(< 55%)的平均半透明带指数(HZI)显著较低;然而,分布重叠表明HZA的鉴别能力较低。发现敏感性为75%,特异性为75%;阳性和阴性预测值分别为81%和68%。

结论

结果表明,HZA和HZI提供了重要信息,可与其他精液特征一起作为辅助生殖中男性因素诊断的有用工具。

相似文献

1
The hemizona assay: its role in identifying male factor infertility in assisted reproduction.半透明带试验:其在辅助生殖中识别男性因素不孕症方面的作用。
Fertil Steril. 1993 May;59(5):1075-80. doi: 10.1016/s0015-0282(16)55931-7.
2
The ability of the hemizona assay to predict human fertilization in different and consecutive in-vitro fertilization cycles.
Hum Reprod. 1993 Aug;8(8):1240-4. doi: 10.1093/oxfordjournals.humrep.a138234.
3
Predictive value of the hemizona assay for pregnancy outcome in patients undergoing controlled ovarian hyperstimulation with intrauterine insemination.半透明带试验对接受控制性卵巢刺激及宫内人工授精患者妊娠结局的预测价值
Fertil Steril. 2006 Jun;85(6):1697-707. doi: 10.1016/j.fertnstert.2005.11.054. Epub 2006 May 6.
4
Comparison of sperm binding potential of uninseminated, inseminated-unfertilized, and fertilized-noncleaved human oocytes under hemizona assay conditions.在半透明带分析条件下未受精、受精未着床和受精未分裂的人类卵母细胞精子结合潜力的比较。
Mol Reprod Dev. 1991 Sep;30(1):56-61. doi: 10.1002/mrd.1080300108.
5
The hemizona assay (HZA): a predictor of human sperm fertilizing potential in in vitro fertilization (IVF) treatment.半透明带分析(HZA):体外受精(IVF)治疗中人类精子受精潜力的预测指标。
J In Vitro Fert Embryo Transf. 1989 Feb;6(1):44-50. doi: 10.1007/BF01134581.
6
Clinical significance of human sperm-zona pellucida binding.
Fertil Steril. 1997 Jun;67(6):1121-7. doi: 10.1016/s0015-0282(97)81449-5.
7
Conditions of oocyte storage and use of noninseminated as compared with inseminated, nonfertilized oocytes for the hemizona assay.与受精的未受精卵母细胞相比,用于半透明带试验的未受精卵母细胞的储存条件及使用情况。
Fertil Steril. 1993 Jul;60(1):131-6. doi: 10.1016/s0015-0282(16)56050-6.
8
The hemizona assay is of good prognostic value for the ability of sperm to fertilize oocytes in vitro.半透明带试验对于精子在体外使卵母细胞受精的能力具有良好的预后价值。
Fertil Steril. 1994 Nov;62(5):1056-9. doi: 10.1016/s0015-0282(16)57073-3.
9
Hemizona index (HZI) demonstrates excellent predictability when evaluating sperm fertilizing capacity in in vitro fertilization patients.
J Androl. 1994 May-Jun;15(3):250-4.
10
The hemizona assay (HZA): development of a diagnostic test for the binding of human spermatozoa to the human hemizona pellucida to predict fertilization potential.半透明带分析(HZA):一种用于检测人类精子与人类半透明带结合以预测受精潜能的诊断测试的开发。
Fertil Steril. 1988 Apr;49(4):688-97.

引用本文的文献

1
Is it necessary to focus on morphologically normal acrosome of sperm during intracytoplasmic sperm injection?在胞质内精子注射过程中,是否有必要关注形态正常的顶体精子?
Indian J Med Res. 2019 Nov;150(5):477-485. doi: 10.4103/ijmr.IJMR_866_18.
2
Selecting patients for embolization of varicoceles based on ultrasonography.基于超声检查选择精索静脉曲张栓塞治疗的患者。
J Ultrason. 2018;18(73):90-95. doi: 10.15557/JoU.2018.0013.
3
Sperm function and assisted reproduction technology.精子功能与辅助生殖技术。
Reprod Med Biol. 2005 Mar 7;4(1):7-30. doi: 10.1111/j.1447-0578.2005.00087.x. eCollection 2005 Mar.
4
Can Ultrasound Findings be a Good Predictor of Sperm Parameters in Patients With Varicocele? A Cross-Sectional Study.超声检查结果能否成为精索静脉曲张患者精子参数的良好预测指标?一项横断面研究。
Nephrourol Mon. 2016 Jul 31;8(5):e37103. doi: 10.5812/numonthly.37103. eCollection 2016 Sep.
5
Assessing the reproductive health of men with occupational exposures.评估职业暴露男性的生殖健康状况。
Asian J Androl. 2014 Jan-Feb;16(1):23-30. doi: 10.4103/1008-682X.122352.
6
Hemizona assay and sperm penetration assay in the prediction of IVF outcome: a systematic review.半透明带试验和精子穿透试验对体外受精结局的预测:一项系统评价
Biomed Res Int. 2013;2013:945825. doi: 10.1155/2013/945825. Epub 2013 Oct 21.
7
The pattern of tyrosine phosphorylation in human sperm in response to binding to zona pellucida or hyaluronic acid.人精子与透明带或透明质酸结合后酪氨酸磷酸化的模式。
Reprod Sci. 2014 May;21(5):573-81. doi: 10.1177/1933719113504467. Epub 2013 Sep 27.
8
Impact of fertilization history and semen parameters on ICSI outcome.受精史和精液参数对卵胞浆内单精子注射结局的影响。
J Assist Reprod Genet. 1998 Jan;15(1):39-45. doi: 10.1023/a:1022578322024.
9
Aging, hyaluronidase removal of the cumulus, and microinjection do not affect the sperm binding potential of human oocytes.衰老、透明质酸酶去除卵丘以及显微注射均不影响人类卵母细胞的精子结合潜能。
J Assist Reprod Genet. 1997 Feb;14(2):97-101. doi: 10.1007/BF02765778.
10
Male infertility: evaluation of human sperm function and its clinical application.男性不育症:人类精子功能评估及其临床应用
J Endocrinol Invest. 1995 Jun;18(6):468-83. doi: 10.1007/BF03349748.